Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.


TSXV:HEM - Post by User

Bullboard Posts
Post by barmac6on Sep 27, 2011 9:49am
253 Views
Post# 19087877

Looks like canaccord vrs TD

Looks like canaccord vrs TD

Depth by Price for T : HEM as of 2011-09-27 09:53:53

Bid Ask
price
#shares
##orders
0.63
7,500
2
0.64
5,900
2
0.65
1,000
1
0.66
47,000
4
0.67
26,000
2
0.70
500
1
0.73
1,000
1
0.77
1,000
1
0.78
1,000
1
0.79
4,500
1

Depth By Price
Bid
Orders Volume Price
2 26,000 0.67
4 47,000 0.66
1 1,000 0.65
2 5,900 0.64
2 7,500 0.63
Ask
Price Volume Orders
0.70 500 1
0.73 1,000 1
0.77 1,000 1
0.78 1,000 1
0.79 4,500 1


House Positions for HEM from 20110927 to 20110927

Ex House Bought $Value Ave Sold $Value Ave Net $Net
33 Canaccord 63,800 42,475 0.67 6,000 4,380 0.73 57,800 -38,095
2 RBC 38,000 26,300 0.69 0 38,000 -26,300
79 CIBC 24,230 15,951 0.66 0 24,230 -15,951
9 BMO Nesbitt 6,000 4,340 0.72 0 6,000 -4,340
89 Raymond James 4,000 2,660 0.67 1,890 1,285 0.68 2,110 -1,375
85 Scotia 1,260 919 0.73 7,000 5,110 0.73 -5,740 4,191
68 Leede 0 6,500 4,745 0.73 -6,500 4,745
1 Anonymous 2,000 1,360 0.68 9,000 6,545 0.73 -7,000 5,185
99 Jitney 500 340 0.68 7,500 5,100 0.68 -7,000 4,760
7 TD Sec 36,600 24,110 0.66 138,500 91,290 0.66 -101,900 67,180
Total 176,390 118,455 0.67 176,390 118,455 0.67 0 0

Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse